Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)

Price and availability

526 012 ₸

Availability

Order now and get it on Wednesday February 24, 2021

Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [Y103] to VEGF Receptor 1 - Low endotoxin, Azide free
  • Suitable for: IP, WB, IHC-P
  • Reacts with: Mouse, Human

You may also be interested in

Anti-PD1 antibody [J43.1] (ab218768)
Product image
Anti-Kallikrein 14 antibody [EPR7209] - BSA and Azide free (ab248246)
Product image
Anti-Nucleoprotein antibody (ab229925)
Product image
Anti-Tspan-9 antibody (ab113775)

Overview

  • Product name

    Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free
    See all VEGF Receptor 1 primary antibodies
  • Description

    Rabbit monoclonal [Y103] to VEGF Receptor 1 - Low endotoxin, Azide free
  • Host species

    Rabbit
  • Tested applications

    Suitable for: IP, WB, IHC-Pmore details
    Unsuitable for: Flow Cyt or ICC/IF
  • Species reactivity

    Reacts with: Mouse, Human
    Predicted to work with: Rat, Chinese hamster
  • Immunogen

    Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.
    (Peptide available as ab182457)

  • Positive control

    • Mouse brain tissue, A431 cells, skin cancer.
  • General notes

    ab184784 is a carrier-free antibody designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

    Our Low endotoxin, azide-free formats have low endotoxin level (≤ 1 EU/ml, determined by the LAL assay) and are free from azide, to achieve consistent experimental results in functional assays.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C. Do Not Freeze.
  • Storage buffer

    pH: 7.20
    Constituent: PBS
  • Carrier free

    Yes
  • Concentration information loading...
  • Purity

    Protein A purified
  • Clonality

    Monoclonal
  • Clone number

    Y103
  • Isotype

    IgG
  • Research areas

    • Cardiovascular
    • Angiogenesis
    • Growth Factors
    • VEGF
    • VEGF Receptors
    • Signal Transduction
    • Protein Phosphorylation
    • Tyrosine Kinases
    • Other
    • Signal Transduction
    • Growth Factors/Hormones
    • VEGF
    • Cancer
    • Growth factors
    • VEGF
    • Cancer
    • Invasion/microenvironment
    • Angiogenesis
    • Angiogenic growth factors
    • Cancer
    • Oncoproteins/suppressors
    • Oncoproteins
    • Growth factors
    • Cardiovascular
    • Vasculature
    • Endothelium
    • Cancer
    • Cancer Metabolism
    • Response to hypoxia
    • Metabolism
    • Pathways and Processes
    • Metabolism processes
    • Hypoxia
    • Cardiovascular
    • Angiogenesis
    • Endothelial Cell Markers

Images

  • Western blot - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)
    Western blot - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)
    Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784) + Mouse brain lysate at 15 µg

    Secondary
    Goat Anti-Rabbit IgG H&L (HRP) (ab97051)

    Predicted band size: 151 kDa


    Exposure time: 8 seconds


    Blocking buffer and concentration: 5% NFDM/TBST

    Diluting buffer and concentration: 5% NFDM/TBST

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)

    Immunohistochemical analysis of paraffin-embedded Human gastric carcinoma tissue labeling VEGF with ab32152, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Cytoplasmic staining on human gastric carcinoma. Counterstained with Hematoxylin. Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

    Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32152).

  • Immunoprecipitation - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)
    Immunoprecipitation - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)

    VEGF Receptor 1 was immunoprecipitated from 0.35 mg mouse brain lysate 10μg with ab32152 at 1:30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab32152 1:1000 dilution (2 μg/ml). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1:1000 dilution.

    Lane 1: Mouse brain lysate 10μg.

    Lane 2: ab32152 IP in mouse brain lysate.

    Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab32152 in mouse brain lysate.

    Blocking and dilution buffer and concentration: 5% NFDM/TBST.

    Exposure time: 1 second.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32152).

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784) Image from Sano M et al. PLoS ONE. 2014 Mar 20; 9(3). Fig 2E. DOI 10.1371/journal.pone.0089830. Lymphangiogenesis and Angiogenesis in Abdominal Aortic Aneurysm. e89830.

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human abdominal aortic aneurysm (AAA) wall tissue sections labeling VEGF Receptor 1 with ab32152 at 1/100 dilution.

    Resected aortic tissues were immersed in 10% neutral buffered formalin for at least 24 h for immunohistochemical staining. Tissue sample was embedded in paraffin; 4 µm sections were cut and mounted onto MAS-coated slides. The sections were deparaffinized, dehydrated, and boiled in a pressure cooker in 0.01 M citric acid buffer (pH 6.0) for 20 min. The sections were washed with phosphate-buffered saline and incubated with 3% H2O2 in absolute methanol for 5 min to inhibit any endogenous peroxidase activity. Sections were preincubated with 3% normal goat serum for 20 min to minimize nonspecific binding to VEGF Receptor 1, and incubated with ab32152 at 4°C overnight in a moist chamber. The section was washed with phosphate-buffered saline and then incubated with the appropriate secondary antibody for 30 min at room temperature. Staining was visualized with Vector DAB, and tissue section was then counterstained with hematoxylin.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32152).

  • Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)
    Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)

  •  
  • Product image

    Anti-VEGF Receptor 1 antibody [EWF] (ab11934)

    Applications: WB

  •  
  • Product image

    Anti-VEGF Receptor 1 antibody [Y103] (ab32152)

    Applications: IHC-P, IP, WB

  •  
  • Product image

    Anti-VEGF Receptor 1 (phospho Y1048) antibody (ab192802)

    Applications: IHC-P

  •  
  • Anti-VEGF Receptor 1 antibody [FLT1658] (ab190712)

    Applications:

  •  
  • Product image

    Anti-VEGF Receptor 1 antibody [EWI] (ab238632)

    Applications: Flow Cyt, WB

  •  
  • Product image

    Anti-VEGF Receptor 1 antibody (ab2350)

    Applications: ICC/IF, IHC-P

  •  
  • Anti-VEGF Receptor 1 antibody [FLT1/658] - BSA and Azide free (ab212369)

    Applications:

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Cytochrome P450 1A2 antibody [d15 (16VII F10F12)] (ab22717)

  •  
  • Product image

    Anti-hnRNP G-T antibody [EPR12593] - BSA and Azide free (ab249879)

  •  
  • Product image

    Human DIAPH1 knockout HEK-293T cell line (ab266120)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.